Paper36077458
PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA.
Kálmán-Szabó I and 11 others. Int J Mol Sci, 2022. Cited by 7 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA. Papers, record 36077458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36077458
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostatic Neoplasms | Major topic |
| Receptors, Bombesin | Major topic |
| Acetates | |
| Animals | |
| Bombesin | |
| Cell Line, Tumor | |
| Gallium Radioisotopes | |
| Heterocyclic Compounds, 1-Ring | |
| Humans | |
| Male | |
| Mice | |
| Positron-Emission Tomography |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32,946,975 | In vivo assessment of aminopeptidase N (APN/CD13) specificity of different 68Ga-labelled NGR derivatives using PET/MRI imaging. | Int J Pharm | 2020 | https://conductscience.org/library/papers/32946975 | PubMed |
| 2 | 27,497,631 | Co-administration of succinylated gelatine with a (99m)Tc-bombesin analogue, effects on pharmacokinetics and tumor uptake. | Nucl Med Biol | 2016 | https://conductscience.org/library/papers/27497631 | PubMed |
| 3 | 19,398,012 | Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues. | Methods | 2009 | https://conductscience.org/library/papers/19398012 | PubMed |
| 4 | 18,383,558 | 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. | Contrast Media Mol Imaging | 2008 | https://conductscience.org/library/papers/18383558 | PubMed |
| 5 | 26,774,390 | Imaging quality of (44)Sc in comparison with five other PET radionuclides using Derenzo phantoms and preclinical PET. | Appl Radiat Isot | 2016 | https://conductscience.org/library/papers/26774390 | PubMed |
| 6 | 25,389,697 | Matching the decay half-life with the biological half-life: ImmunoPET imaging with (44)Sc-labeled cetuximab Fab fragment. | Bioconjug Chem | 2014 | https://conductscience.org/library/papers/25389697 | PubMed |
| 7 | 8,022,709 | Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells. | Prostate | 1994 | https://conductscience.org/library/papers/8022709 | PubMed |
| 8 | 28,102,507 | 44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617-preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617. | EJNMMI Res | 2017 | https://conductscience.org/library/papers/28102507 | PubMed |
| 9 | 35,745,585 | Synthesis, Physicochemical, Labeling and In Vivo Characterization of 44Sc-Labeled DO3AM-NI as a Hypoxia-Sensitive PET Probe. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35745585 | PubMed |
| 10 | 19,115,523 | Regulation and signaling of human bombesin receptors and their biological effects. | Curr Opin Endocrinol Diabetes Obes | 2009 | https://conductscience.org/library/papers/19115523 | PubMed |
| 11 | 28,097,756 | AAZTA: An Ideal Chelating Agent for the Development of 44 Sc PET Imaging Agents. | Angew Chem Int Ed Engl | 2017 | https://conductscience.org/library/papers/28097756 | PubMed |
| 12 | 22,682,112 | Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET. | EJNMMI Res | 2012 | https://conductscience.org/library/papers/22682112 | PubMed |
| 13 | 2,390,263 | Bombesin increases fetal lung growth and maturation in utero and in organ culture. | Am J Respir Cell Mol Biol | 1990 | https://conductscience.org/library/papers/2390263 | PubMed |
| 14 | 23,649,462 | Functional and molecular imaging of localized and recurrent prostate cancer. | Eur J Nucl Med Mol Imaging | 2013 | https://conductscience.org/library/papers/23649462 | PubMed |
| 15 | 2,539,244 | Bombesin stimulates growth of human prostatic cancer cells in vitro. | Cancer | 1989 | https://conductscience.org/library/papers/2539244 | PubMed |
| 16 | 29,564,385 | 44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations. | EJNMMI Radiopharm Chem | 2017 | https://conductscience.org/library/papers/29564385 | PubMed |
| 17 | 20,182,713 | A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues. | Eur J Nucl Med Mol Imaging | 2010 | https://conductscience.org/library/papers/20182713 | PubMed |
| 18 | 21,680,701 | PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference. | J Nucl Med | 2011 | https://conductscience.org/library/papers/21680701 | PubMed |
| 19 | 7,902,829 | Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice. | Int J Cancer | 1993 | https://conductscience.org/library/papers/7902829 | PubMed |
| 20 | 26,561,028 | In Vivo Evaluation of a Bombesin Analogue Labeled with Ga-68 and Co-55/57. | Mol Imaging Biol | 2016 | https://conductscience.org/library/papers/26561028 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,339,117 | The gastrin-releasing peptide receptor in oncology: a comprehensive review of recent advances in targeted radionuclide theranostics. | Front Oncol | 2026 | https://conductscience.org/library/papers/42339117 | PubMed |
| 41,425,801 | Functional D- and L‑Naphthalenediimide-Peptides: Microwave-Driven Synthesis, Supramolecular Aggregation, and Multiphoton Fluorescence Lifetime Imaging Microscopy in Living Cells. | ACS Bio Med Chem Au | 2025 | https://conductscience.org/library/papers/41425801 | PubMed |
| 41,217,470 | A true theranostic pair - 44/47Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/41217470 | PubMed |
| 39,474,267 | Peptide PET Imaging: A Review of Recent Developments and a Look at the Future of Radiometal-Labeled Peptides in Medicine. | Chem Biomed Imaging | 2024 | https://conductscience.org/library/papers/39474267 | PubMed |
| 38,020,178 | GRPR-targeting radiotheranostics for breast cancer management. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/38020178 | PubMed |
| 37,108,559 | Scandium-44: Diagnostic Feasibility in Tumor-Related Angiogenesis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108559 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GRP | 2,922 | PubTator's text mining | https://conductscience.org/library/genes/2922 | NCBI Gene |
| GRPR | 2,925 | PubTator's text mining | https://conductscience.org/library/genes/2925 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36077458
GET https://conductscience.org/api/papers/v1/36077458/references?page=2